Evidence map›Paper›PMID 37022012›Full record

ArticleCancer medicine2023

The COVID-19 Pandemic's impact on sustainability and expansion of a Pediatric Early Warning System in resource-limited hospitals.

Parima P Wiphatphumiprates, Dylan E Graetz, Gia Ferrara, Maria Puerto-Torres, Srinithya R Gillipelli, Paul Elish, Hilmarie Muniz-Talavera, Alejandra Gonzalez-Ruiz, Miriam Armenta, Camila Barra and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 6 countries.

Parima P WiphatphumipratesRhodes College, Memphis, Tennessee, USA.ORCID 0000-0001-8297-9635
Dylan E GraetzGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.ORCID 0000-0002-4541-6910
Gia FerraraGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.ORCID 0000-0002-3435-8436
Maria Puerto-TorresGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.
Srinithya R GillipelliBaylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-9039-4693
Paul ElishRollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Hilmarie Muniz-TalaveraGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.
Alejandra Gonzalez-RuizGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.
Miriam ArmentaPediatric Oncology, Hospital General de Tijuana, Tijuana, Mexico.
Camila BarraPediatric Oncology, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
Zulma CarpioPediatric Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Cinthia HernandezPediatric Oncology, Hospital Infantil Teletón de Oncología, Querétaro, Mexico.
Susana JuarezPediatrics, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico.
Jose de Jesus LoezaPediatric Oncology, Centro Estatal de Cancerología, Xalapa, Mexico.
Alejandra MendezPediatric Critical Care, Unidad Nacional de Oncología Pediátrica, Guatemala City, Guatemala.
Erika MontalvoPediatric Critical Care, Hospital Oncológico Solca Núcleo de Quito, Quito, Ecuador.
Eulalia PenafielPediatric Oncology, Instituto del Cáncer SOLCA Cuenca, Cuenca, Ecuador.
Estuardo PinedaPediatric Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador.
Virginia McKayBloom School of Medicine, Washington University, St. Louis, Missouri, USA.
Asya AgulnikGlobal Pediatric Medicine at St. Jude Children's Research Hospital, Tennessee, Memphis, USA.ORCID 0000-0001-8932-8181
St. Jude Children's Research Hospital · USBaylor College of Medicine · USEmory University · USHospital Central Dr. Ignacio Morones Prieto · MXHospital Luis Calvo Mackenna · CLHospital Nacional de Niños Bloom · SVHospital Vozandes · ECInstituto Nacional de Enfermedades Neoplásicas · PERhodes College · USUniversidad de Tijuana · MXUniversidad de Xalapa · MXWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic impacted healthcare delivery worldwide, including pediatric cancer care, with a disproportionate effect in resource-limited settings. This study evaluates its impact on existing quality improvement (QI) programs.

methodsWe conducted 71 semi-structured interviews of key stakeholders at five resource-limited pediatric oncology centers participating in a collaborative to implement Pediatric Early Warning System (PEWS). Interviews were conducted virtually using a structured interview guide, recorded, transcribed, and translated into English. Two coders developed a codebook of a priori and inductive codes and independently coded all transcripts, achieving a kappa of 0.8-0.9. Thematic analysis explored the impact of the pandemic on PEWS.

resultsAll hospitals reported limitations in material resources, reduction in staffing, and impacts on patient care due to the pandemic. However, the impact on PEWS varied across centers. Identified factors that promoted or limited ongoing PEWS use included the availability of material resources needed for PEWS, staff turnover, PEWS training for staff, and the willingness of staff and hospital leaders to prioritize PEWS. Consequently, some hospitals were able to sustain PEWS; others halted or reduced PEWS use to prioritize other work. Similarly, the pandemic delayed plans at all hospitals to expand PEWS to other units. Several participants were hopeful for future expansion of PEWS post-pandemic.

conclusionThe COVID-19 pandemic created challenges for sustainability and scale of PEWS, an ongoing QI program, in these resource-limited pediatric oncology centers. Several factors mitigated these challenges and promoted ongoing PEWS use. These results can guide strategies to sustain effective QI interventions during future health crises.

Indexed as

COVID-19NeoplasmsChildDelivery of Health CareHospitalsHumansPandemicsCOVID-19implementation scienceLatin Americapediatric early warning systempediatric oncologyPEWSquality improvement collaborativeresource-limited

Identifiers

PMID37022012
PMCPMC10242859
OpenAlexW4362657535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.